Human iPSC-derived cortical neurons and co-culture as translational platforms for modeling neurodegeneration

Poster - Human iPSC-derived cortical neurons and co-culture as translational platforms for modeling neurodegeneration

Abstract

The FDA Modernization Act 2.0 invites alternatives to animal testing, to improve the translational success of clinical drug candidates. Human induced pluripotent stem cell (hiPSC)-derived models offer a more physiologically relevant background for pre-clinical assessment. Here, we investigate the activation state of microglia in response to LPS and assess inter batch and inter assay variability of control (ax0664) microglia.

Additionally, iPSC-derived cortical neurons from donors affected by sporadic Alzheimer’s disease (sAD) were matured and characterized in terms of neurite outgrowth and response to stressors such as Tau PFFs1,2. Incorporating cells derived from donors with sAD into quad-culture alongside the use of physiologically relevant stressors provides a useful human cell platform to test therapies for neurodegeneration.

We have also developed a quad-culture model supporting function of iPSC-derived, isogenic, cortical excitatory and inhibitory neurons, microglia and astrocytes. Spontaneous neuronal activity (SNA) was monitored using IncuCyte® Neuroburst (Sartorius) and markers of each cell type examined by immunocytochemistry. Microglial addition increased neuronal activity and synchronisation. As clinical trials for dementia increasingly include drugs targeting neuroinflammation, co-culture of neurons and glia is a relevant model for in vitro compound screening.